Aspects related to sample collection in the detection of SARS-CoV-2 in Villa Clara
Keywords:
SARS-Cov-2, COVID-19, specimen handlingAbstract
Introduction: based on the report of a cluster of pneumonia cases of unknown etiology on December 31, 2019 in Wuhan, China, the World Health Organization declared the outbreak to be a public health emergency of international concern; COVID-19 became a pandemic. The process of collecting the sample in the detection of SARS-CoV-2 represents one of the initial and highly relevant stages for carrying out an efficient and robust diagnosis.Objective: to characterize aspects related to the detection of SARS-CoV-2 and the taking of samples in the Province of Villa Clara.
Methods: a descriptive, observational, retrospective investigation was carried out with the objective of characterizing aspects related to the detection of SARS-CoV-2 and the taking of samples in the Province of Villa Clara from the 157 confirmed cases with the disease in the period of study.
Results: more than half of the cases were taken for bilateral nasal exudate, with a mean threshold cycle of 27.9, with a standard deviation of 7.1. 53.3% of the means of transport corresponded to the Sensure Biotech brand; this type of transport medium was the one with the most samples, with a threshold cycle below 20.
Conclusions: the sample with the highest positivity was the bilateral nasal exudate, which coincides with international authors. Of the means of transport evaluated, Sensure Biotech was the one that offered the best results. In the case of asymptomatic patients, the sample that presented the best results was bilateral nasal exudate.
Downloads
References
1.Más Bermejo P, Vidal Ledo MJ, Baldoquín Rodríguez W, Seuc Jo AH, Guinovart Díaz R, Noriega Bravo V, et al. Organización de la investigación epidemiológica para la lucha antiepidémica contra la COVID-19 en Cuba. INFODIR [Internet]. 2020 [citado 11/07/2020];32:e831. Disponible en: http://www.revinfodir.sld.cu/index.php/infodir/article/view/831
2.Pastrian-Soto G. Bases Genéticas y Moleculares del COVID-19 (SARS-CoV-2). Mecanismos de Patogénesis y de Respuesta Inmune. Int J Odontostomat [Internet]. 2020 Sep [citado 11/07/2020];14(3):331-337. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-381X2020000300331. http://dx.doi.org/10.4067/S0718-381X2020000300331
3.Araujo Oliveira B, Campos de Oliveira L, Cerdeira Sabino E, Suely Okay T. SARS-CoV-2 and the COVID-19 disease: a mini review on diagnostic methods. Rev Inst Med Trop S Paulo [Internet]. 2020 [citado 11/07/2020];62:e44. Disponible en: https://www.scielo.br/j/rimtsp/a/7r4dYzS8rhQdmZbxf4mZkzB/?lang=en. https://doi.org/10.1590/S1678-9946202062044
4.Organización Panamericana de la Salud. Directrices de laboratorio para la detección y el diagnóstico de la infección por el virus responsable de la COVID-19 [Internet]. Washington DC: OPS; 2020 [citado 11/07/2020]. Disponible en: https://iris.paho.org/handle/10665.2/52471
5.Díaz Cabrera A, Vidal Carreño F, Adasme Jeria R, Arellano Sepúlveda D, Figueroa González P. Guía para toma de muestras respiratorias en pacientes con sospecha de infección por coronavirus (COVID-19) [Internet]. Santiago de Chile: Sociedad Chilena de Medicina Intensiva; 2020 [citado 11/07/2020]. Disponible en: https://www.medicina-intensiva.cl/site/covid/guias/guia_toma_muestras_respiratorias_pacientes_con_sospecha_de_COVID_19.pdf
6.Morales-Angulo C, González-Zubizarreta R, Martin-Toca G, Ramirez Bonilla A, Gozalo Margüello M, Rodriguez-Fernández A. Toma de muestras nasofaríngeas para diagnóstico de covid-19. Rev ORL [Internet]. 2020 [citado 20/07/2020];11(4):389-394. Disponible en: https://revistas.usal.es/index.php/2444-7986/article/view/23079/25050. https://doi.org/10.14201/orl.23079
7.Más Bermejo PI. La COVID 19 y la práctica epidemiológica en Cuba. Rev Cubana Hig Epidemiol [Internet]. 2020 [citado 11/07/2020];57:e307. Disponible en: http://www.revepidemiologia.sld.cu/index.php/hie/article/view/307
8.Ferrer Castro JE, Sánchez Hernández E, Poulout Mendoza A, del Río Caballero G, Figueredo Sánchez D. Caracterización clínica y epidemiológica de pacientes confirmados con la COVID-19 en la provincia de Santiago de Cuba. MEDISAN [Internet]. 2020 [citado 24/07/2020];24(3):473-485. Disponible en: http://medisan.sld.cu/index.php/san/article/view/3145/html
9.González-Lorenzo L, Abreu Duarte R, Castro-Martínez JA. Experiencias en la toma de muestras ante la Covid-19 en Villa Clara. INFODIR [Internet]. 2020 [citado 29/07/2020];33:[aprox. 7 p.]. Disponible en: http://www.revinfodir.sld.cu/index.php/infodir/article/view/886
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).